| Price | $3.72 |
| Year Range | $3.33 – $102.5 |
| Market Cap | $5M |
| Industry | Biotechnology |
What Is Liminatus Pharma’s AI Stock Analysis?
Liminatus Pharma’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks Liminatus Pharma’s momentum in near-real time.
Liminatus Pharma (LIMN) has an AltIndex AI Score of 50/100, currently a Hold signal. The AI Score distills Liminatus Pharma's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.
Liminatus Pharma’s Full AI Analysis
Keep reading AltIndex’s full AI analysis of Liminatus Pharma — the fundamental, technical and alternative-data breakdown and the recommendation.
Sign up to read the full analysisWhat’s Driving LIMN’s AI Score?
Technicals
Today's stock price is $3.72. This is an increase of 6.90% compared to a month ago, indicating a positive short-term trend. However, compared to a year ago, there is a decrease of 94.72%, which could be a cause for long-term concern. The trend is bearish. The current SMA10 is $3.82, which is lower than the previous SMA10 of $3.84. This suggests a potential downward trend in price movement. The RSI is 31.9, indicating a neutral condition.
See the full technical analysis and price prediction.
Frequently Asked Questions: Liminatus Pharma AI Stock Analysis
Liminatus Pharma's AltIndex AI Score is 50/100, currently a Hold signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.
AltIndex's AI Score model rates Liminatus Pharma a Hold (50/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.
The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.
AltIndex generates a complete written AI analysis of Liminatus Pharma — company overview, fundamentals, technicals and alternative data, with a recommendation. See the LIMN AI Score or sign up to read the full thesis.
